Data as of Nov 4, 2026.

vsOpen in the appCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Thematic ETFs

BBC vs IDNA: Holdings Overlap & Returns

Share
Share on XDownload as PDF

Over the year to Nov 4, 2026, BBC returned +45.9% to IDNA's +81.1%; 7% of their weight is in the same names.

askIQ about this page

askIQ about BBC and IDNA

Net assets: $46m on Jul 31, 2026 for Virtus Biotech Clinical Trials ETF, and $340m on Nov 3, 2026 for iShares Genomics Immunology and Healthcare ETF.

At a glance
0.0%
BBC in the S&P 500
27.4%
IDNA in the S&P 500
+45.9%
BBC total return, 1 year
+81.1%
IDNA total return, 1 year
BBC · 1 year to Nov 4, 2026 100% of its weight is outside the S&P 500
100% of its weight is outside the S&P 5000% of BBC's weight is in S&P 500 companies and 100% is outside the index. Holdings as of Jul 31, 2026.0%100%0% of its weight in S&P 500 companiesof its weight outside the S&P 500active share 100% · top ten 12% of the fund · 131 holdings as filed for Jul 31, 2026 · Nasdaq-100: 0% in100% of its weight is outside the S&P 5000% of BBC's weight is in S&P 500 companies and 100% is outside the index. Holdings as of Jul 31, 2026.0%100%0% of its weight in S&P 500 companiesof its weight outside the S&P 500active share 100% · Nasdaq-100: 0% in

0% of BBC's weight is in S&P 500 companies and 100% is outside the index. Holdings as of Jul 31, 2026.

IDNA · 1 year to Nov 4, 2026 73% of its weight is outside the S&P 500
73% of its weight is outside the S&P 50027% of IDNA's weight is in S&P 500 companies and 73% is outside the index. Holdings as of Nov 3, 2026.27%73%in the S&P 500of its weight outside the S&P 500active share 99% · top ten 51% of the fund · 52 holdings as published by its issuer for Nov 3, 2026 · Nasdaq-100: 8% in73% of its weight is outside the S&P 50027% of IDNA's weight is in S&P 500 companies and 73% is outside the index. Holdings as of Nov 3, 2026.27%73%inoutside the S&P 500active share 99% · Nasdaq-100: 8% in

27% of IDNA's weight is in S&P 500 companies and 73% is outside the index. Holdings as of Nov 3, 2026.

Pair scorecard

IDNA costs 0.18 points a year less; their one-year returns differ by 35.2 points.

BBC vs IDNA: Holdings Overlap & Returns
MeasureBBCIDNA
Return
Total return, 1 year+45.9%+81.1%
Drawdown
Below its all-time high27.4%, high on Feb 8, 202116.5%, high on Sep 2, 2021
Benchmark
What it tracksBiotechGenomics and gene editing
Cost and size
Expense ratio0.65%0.47%
Net assets, BBC as of Jul 31, 2026 and IDNA as of Nov 3, 2026$46m$340m
Holdings
Holdings in common7%

Method

What they share

7%

By the books each fund has filed, BBC and IDNA hold 7% of their money in the same securities at the same weight. Holdings dated Jul 31, 2026 and Nov 3, 2026.

0 half 100%

half

7% in common

Positions both hold · largest shared weight first BBC IDNA
IDEAYA BIOSCIENCES INC 0.82% 2.26%
REVOLUTION MEDICINES INC 0.82% 3.60%
ARCUS BIOSCIENCES INC 0.79% 1.37%
JANUX THERAPEUTICS INC 0.75% 0.89%
ABCELLERA BIOLOGICS INC 0.73% 2.48%
VIR BIOTECHNOLOGY INC 0.67% 1.30%
XENCOR INC 1.10% 0.60%
CORVUS PHARMACEUTICALS INC 0.74% 0.54%
INTELLIA THERAPEUTICS INC 0.59% 0.44%
DESIGN THERAPEUTICS INC 0.74% 0.34%
CYTOMX THERAPEUTICS INC 0.69% 0.33%
PRIME MEDICINE INC 0.70% 0.12%
Only in one fund ↓
Only in BBC
FIRST TRACKS BIOTHERAPEUTICS INC 1.67%
MBX BIOSCIENCES INC 1.24%
ATAIBECKLEY INC 1.23%
MONOPAR THERAPEUTICS INC 1.21%
DEFINIUM THERAPEUTICS INC 1.18%
ZENAS BIOPHARMA INC 1.06%
UNIQURE NV 1.06%
APOGEE THERAPEUTICS INC 1.02%
Only in IDNA
MODERNA 13.33%
GENMAB 6.26%
TWIST BIOSCIENCE 5.61%
REGENERON PHARMACEUTICALS 4.24%
BAYER AG 3.85%
EXELIXIS INC 3.80%
TAKEDA PHARMACEUTICAL 3.77%
CARIS LIFE SCIENCES 3.50%
Check overlap with more funds →

Window by window

Window by window: BBC vs IDNA: Holdings Overlap & Returns
Total return
WindowBBCIDNA
3 months−14.8%+32.4%
6 months−5.2%+45.6%
1 year+45.9%+81.1%
3 years+132.0%+134.8%
Since launchNot the same days: BBC Dec 2014 · IDNA Jun 2019+72.8%+88.1%

Open this comparison in the app →

Side by side

BBC Virtus Biotech Clinical Trials ETF · Holds 131 stocks in biotech, 0% of its weight in S&P 500 companies IDNA iShares Genomics Immunology and Healthcare ETF · Holds 52 stocks in genomics and gene editing, 27% of its weight in S&P 500 companies
Theme Biotech Genomics and gene editing
In the S&P 500 0.0% 27.4%
Active share vs the S&P 500 100.0% 99.1%
In the Nasdaq-100 0.0% 7.5%
Holdings 131 52
Top ten, share of the fund 11.8% 51.3%
Expense ratio 0.65% 0.47%
Fee for the differing part 0.65% 0.47%
Total return, 1 year +45.9% +81.1%
vs its benchmark not measured not measured
Below its high −27.4% −16.5%
Net assets, BBC as of Jul 31, 2026 and IDNA as of Nov 3, 2026 $46m $340m

As of Nov 4, 2026. Source: ETFIQ.

7% of the two portfolios are the same securities at the same weight.

Alert

IDNA flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
BBC

By weight, 0% of BBC's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 12% of the fund across 131 positions, as filed for Jul 31, 2026. Over the year to Nov 4, 2026 the fund returned +45.9% with distributions reinvested. It sits 27.4% below its all-time high of Feb 8, 2021.

IDNA

By weight, 27% of IDNA's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 51% of the fund across 52 positions, as published by its issuer for Nov 3, 2026. Over the year to Nov 4, 2026 the fund returned +81.1% with distributions reinvested. It sits 16.5% below its all-time high of Sep 2, 2021.

Questions people ask

Do BBC and IDNA hold the same stocks?
By their latest filings, 7% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, BBC or IDNA?
BBC has 0% of its weight in S&P 500 names and IDNA has 27%, so BBC differs more from the index.
Which is cheaper, BBC or IDNA?
BBC charges 0.65% a year and IDNA charges 0.47%, so IDNA is cheaper. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, BBC against IDNA, data as of Nov 4, 2026. https://etfiq.com/compare/themes/bbc-vs-idna

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.